Results
1 -
10 of
12Reversal of multidrug resistance by a novel quinoline derivative, MS-209, Cancer Chemotherapy and Pharmacology Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells, Cancer Chemotherapy and Pharmacology Multidrug resistance pglycoprotein function of bone marrow hematopoietic cells and the reversal agent effect, Journal of Tongji Medical University Drug resistance in chemotherapy for breast cancer, Cancer Chemotherapy and Pharmacology Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil, Cancer Chemotherapy and Pharmacology New multidrug-resistance-reversing drugs, MS-209 and SDZ PSC 833, Cancer Chemotherapy and Pharmacology P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel, Cancer Chemotherapy and Pharmacology Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging, European Journal of Nuclear Medicine and Molecular Imaging A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene, Cancer Chemotherapy and Pharmacology A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients, European Journal of Clinical Microbiology & Infectious Diseases